Evidence map›Paper›PMID 35040953›Full record

ArticleFEMS yeast research2022

Unraveling the potential of non-conventional yeasts in biotechnology.

C Geijer, R Ledesma-Amaro, E Tomás-Pejó

Abstract read
In one paragraph

Article in FEMS yeast research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. New insights into carbon metabolism in SFrontiers in fungal biology · 2025
    Article
  18. Article
  19. Article
  20. Bioengineered · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C GeijerDepartment of Biology and Biological Engineering, Chalmers University of Technology, Kemivägen 10, Gothenburg 412 96, Sweden.
R Ledesma-AmaroDepartment of Bioengineering and Imperial College Centre for Synthetic Biology, South Kensington Campus, 702 Bessemer Building, Imperial College London, London SW7 2AZ, UK.
E Tomás-PejóBiotechnological Processes Unit, IMDEA Energy, Av. Ramón de la Sagra, Móstoles 28935, Madrid, Spain.ORCID 0000-0003-3554-4510

Funding

Chalmers University of TechnologyEuropean Cooperation in Science and Technology
6 · The paper itself

Abstract

Cost-effective microbial conversion processes of renewable feedstock into biofuels and biochemicals are of utmost importance for the establishment of a robust bioeconomy. Conventional baker's yeast Saccharomyces cerevisiae, widely employed in biotechnology for decades, lacks many of the desired traits for such bioprocesses like utilization of complex carbon sources or low tolerance towards challenging conditions. Many non-conventional yeasts (NCY) present these capabilities, and they are therefore forecasted to play key roles in future biotechnological production processes. For successful implementation of NCY in biotechnology, several challenges including generation of alternative carbon sources, development of tailored NCY and optimization of the fermentation conditions are crucial for maximizing bioproduct yields and titers. Addressing these challenges requires a multidisciplinary approach that is facilitated through the 'YEAST4BIO' COST action. YEAST4BIO fosters integrative investigations aimed at filling knowledge gaps and excelling research and innovation, which can improve biotechnological conversion processes from renewable resources to mitigate climate change and boost transition towards a circular bioeconomy. In this perspective, the main challenges and research efforts within YEAST4BIO are discussed, highlighting the importance of collaboration and knowledge exchange for progression in this research field.

Indexed as

BiotechnologyMetabolic EngineeringBiofuelsFermentationSaccharomyces cerevisiaeYeastsBiofuelsbiochemicalsbiofuelslignocellulosic sugarsnon-conventional yeastsvolatile fatty acids

Identifiers

PMID35040953
PMCPMC8793870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.